T

Tri Locum Partners LP Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Tri Locum Partners LP with $435.1M in long positions as of Q3 2025, 85% allocated to Healthcare, and 84% concentrated in top 10 positions.

Portfolio Value
$435.1M
Top 10 Concentration
84%
Top Sector
Healthcare (85%)
US Exposure
92%
Market Cap Focus
Mega Cap
Countries
4

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 84.70%Healthcare
Healthcare
84.70%

Industry Breakdown

4 industries across all sectors

Biotechnology: 53.84%BiotechnologyDrug Manufacturers - General: 26.30%Drug Manufacturers - GeneralDrug Manufacturers - Specialty & Generic: 2.54%Medical - Instruments & Supplies: 1.97%
Biotechnology
Healthcare
53.84%
Drug Manufacturers - General
Healthcare
26.30%
Drug Manufacturers - Specialty & Generic
Healthcare
2.54%
Medical - Instruments & Supplies
Healthcare
1.97%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mega Cap (> $200B): 26.30%Mega Cap (> $200B)Large Cap ($10B - $200B): 18.91%Large Cap ($10B - $200B)Mid Cap ($2B - $10B): 22.13%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 17.31%Small Cap ($300M - $2B)N/A (ETF or Unknown): 15.35%N/A (ETF or Unknown)
Mega Cap (> $200B)
26.30%
Large Cap ($10B - $200B)
18.91%
Mid Cap ($2B - $10B)
22.13%
Small Cap ($300M - $2B)
17.31%
N/A (ETF or Unknown)
15.35%

Portfolio Concentration

Top 10 Holdings %
83.67%
Top 20 Holdings %
100.0%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
92.11%
International
7.89%
Countries
4
Largest Int'l Market
Canada - 3.38%
United States of America
92.11% ($400.7M)
15 holdings
Canada
3.38% ($14.7M)
1 holdings
Ireland
2.54% ($11.1M)
1 holdings
Italy
1.97% ($8.6M)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
3.7 quarters
Avg. Top 20
4.1 quarters
Avg. All Positions
4.1 quarters
Median Holding Period
2 quarters
Persistence Rate
44.44%
Persistent Holdings Weight
32.33%
Persistent Positions
8
Longest Held
Madrigal Pharmaceuticals, Inc. Common Stock logo
Madrigal Pharmaceuticals, Inc. Common StockMDGL - 11 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
1.65%
Avg. Position Weight
5.56%
Largest Position
Johnson & Johnson logo
Johnson & JohnsonJNJ - 12.91%
Largest Ownership Stake
Korro Bio, Inc. Common Stock logo
Korro Bio, Inc. Common StockKRRO - 3.60%
Avg. Ownership Stake
0.50%
Ownership Stake >5%
0
Ownership Stake >1%
2

Historical (Since Q4 2020)

Avg. New Position
1.78%
Avg. Ownership Stake
0.38%
Largest Position
Cellectar Biosciences INC NEW logo
Cellectar Biosciences INC NEWCLRB - 63.53% (Q4 2020)
Largest Ownership Stake
X4 Pharmaceuticals, Inc. Common Stock logo
X4 Pharmaceuticals, Inc. Common StockXFOR - 5.64% (Q2 2022)

Portfolio Turnover

Current Quarter

Turnover Ratio
50.2%
Value Traded
$218.33M
Positions Added
1
Positions Exited
11

Historical (Since Q4 2020)

Avg. Turnover Ratio
60.4%
Avg. Positions Added
15
Avg. Positions Exited
19
Highest Turnover
124.3%
Q1 2021
Lowest Turnover
34.2%
Q3 2024

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.